146 related articles for article (PubMed ID: 35140170)
1. IQOS marketing strategies at point-of-sales: a cross-sectional survey with retailers.
Bar-Zeev Y; Berg CJ; Khayat A; Romm KF; Wysota CN; Abroms LC; Elbaz D; Levine H
Tob Control; 2023 Aug; 32(e2):e198-e204. PubMed ID: 35140170
[TBL] [Abstract][Full Text] [Related]
2. IQOS point-of-sale marketing: a comparison between Arab and Jewish neighborhoods in Israel.
Khayat A; Levine H; Berg CJ; Abroms LC; Duan Z; Wang Y; LoParco CR; Elbaz D; Cui Y; Bar-Zeev Y
Res Sq; 2024 Mar; ():. PubMed ID: 38464035
[TBL] [Abstract][Full Text] [Related]
3. IQOS point-of-sale marketing strategies in Israel: a pilot study.
Bar-Zeev Y; Levine H; Rubinstein G; Khateb I; Berg CJ
Isr J Health Policy Res; 2019 Jan; 8(1):11. PubMed ID: 30642383
[TBL] [Abstract][Full Text] [Related]
4. Assessment of IQOS Marketing Strategies at Points-of-Sale in Israel at a Time of Regulatory Transition.
Bar-Zeev Y; Berg CJ; Abroms LC; Rodnay M; Elbaz D; Khayat A; Levine H
Nicotine Tob Res; 2022 Jan; 24(1):100-108. PubMed ID: 34216461
[TBL] [Abstract][Full Text] [Related]
5. Low compliance and proliferation of IQOS purchase cues at points-of-sale: a comparative study before and after Israel's display ban.
Bar-Zeev Y; Berg CJ; Khayat A; Abroms LC; Wang Y; Duan Z; LoParco CR; Cui Y; Elbaz D; Levine H
Tob Control; 2024 Jun; ():. PubMed ID: 38862232
[TBL] [Abstract][Full Text] [Related]
6. PMI's IQOS and cigarette ads in Israeli media: a content analysis across regulatory periods and target population subgroups.
Khayat A; Berg CJ; Levine H; Rodnay M; Abroms L; Romm KF; Duan Z; Bar-Zeev Y
Tob Control; 2024 Mar; 33(e1):e54-e61. PubMed ID: 36418166
[TBL] [Abstract][Full Text] [Related]
7. Brief report on IQOS point-of-sale marketing, promotion and pricing in IQOS retail partner stores in Atlanta, Georgia, USA.
Henderson KC; Van Do V; Wang Y; Duan Z; Popova L; Spears CA; Weaver SR; Ashley DL; Barker DC; Huang J
Tob Control; 2023 Aug; 32(e2):e260-e264. PubMed ID: 35918133
[TBL] [Abstract][Full Text] [Related]
8. Point-of-sale marketing of heated tobacco products in Israel: cause for concern.
Halpern-Felsher B
Isr J Health Policy Res; 2019 May; 8(1):47. PubMed ID: 31133053
[TBL] [Abstract][Full Text] [Related]
9. IQOS: examination of Philip Morris International's claim of reduced exposure.
St Helen G; Jacob Iii P; Nardone N; Benowitz NL
Tob Control; 2018 Nov; 27(Suppl 1):s30-s36. PubMed ID: 30158205
[TBL] [Abstract][Full Text] [Related]
10. Industry marketing of tobacco products on social media: case study of Philip Morris International's IQOS.
Abroms LC; Wysota CN; Tosakoon S; Khayat A; Duan Z; Bar-Zeev Y; Berg CJ; Levine H
Tob Control; 2024 Jun; 33(4):518-524. PubMed ID: 36927516
[TBL] [Abstract][Full Text] [Related]
11. FDA's reduced exposure marketing order for IQOS: why it is not a reliable global model.
Lempert LK; Bialous S; Glantz S
Tob Control; 2022 Aug; 31(e1):e83-e87. PubMed ID: 33811155
[TBL] [Abstract][Full Text] [Related]
12. Marketing IQOS in a dark market.
Mathers A; Schwartz R; O'Connor S; Fung M; Diemert L
Tob Control; 2019 Mar; 28(2):237-238. PubMed ID: 29724866
[TBL] [Abstract][Full Text] [Related]
13. Heated tobacco products likely appeal to adolescents and young adults.
McKelvey K; Popova L; Kim M; Chaffee BW; Vijayaraghavan M; Ling P; Halpern-Felsher B
Tob Control; 2018 Nov; 27(Suppl 1):s41-s47. PubMed ID: 30352843
[TBL] [Abstract][Full Text] [Related]
14. Determining the impact of smoking point of sale legislation among youth (Display) study: a protocol for an evaluation of public health policy.
Haw S; Amos A; Eadie D; Frank J; MacDonald L; MacKintosh AM; MacGregor A; Miller M; Pearce J; Sharp C; Stead M; Tisch C; van der Sluijs W
BMC Public Health; 2014 Mar; 14():251. PubMed ID: 24628879
[TBL] [Abstract][Full Text] [Related]
15. "It Looks Like an Adult Sweetie Shop": Point-of-Sale Tobacco Display Exposure and Brand Awareness in Scottish Secondary School Students.
van der Sluijs W; Haseen F; Miller M; MacGregor A; Sharp C; Amos A; Best C; Stead M; Eadie D; Pearce J; Frank J; Haw S
Nicotine Tob Res; 2016 Oct; 18(10):1981-1988. PubMed ID: 26883750
[TBL] [Abstract][Full Text] [Related]
16. Point-of-Sale Tobacco Advertising and Display Bans: Policy Evaluation Study in Five Russian Cities.
Kennedy RD; Grant A; Spires M; Cohen JE
JMIR Public Health Surveill; 2017 Aug; 3(3):e52. PubMed ID: 28811269
[TBL] [Abstract][Full Text] [Related]
17. Tobacco and E-Cigarettes Point of Sale Advertising-Assessing Compliance with Tobacco Advertising, Promotion and Sponsorship Bans in Poland.
Polanska K; Kaleta D
Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33670741
[TBL] [Abstract][Full Text] [Related]
18. 'The last line of marketing': Covert tobacco marketing tactics as revealed by former tobacco industry employees.
Watts C; Burton S; Freeman B
Glob Public Health; 2021 Jul; 16(7):1000-1013. PubMed ID: 32946326
[TBL] [Abstract][Full Text] [Related]
19. Effect of IQOS introduction on Philip Morris International cigarette sales in Spain: a Logarithmic Mean Divisa Index decomposition approach.
Golpe AA; Martín-Álvarez JM; Galiano A; Asensio E
Gac Sanit; 2022; 36(4):293-300. PubMed ID: 35219532
[TBL] [Abstract][Full Text] [Related]
20. Tobacco Retailers' Support for Point-of-Sale Tobacco Control Policies in England: Association Study of Retailers' Perceived Importance of Tobacco Sales, Contact with the Tobacco Industry, and the Perceived Impact of the Policy.
van Deelen TRD; Arnott D; Hitchman S; van den Putte B; Kunst AE; Kuipers MAG
Nicotine Tob Res; 2022 Apr; 24(6):813-819. PubMed ID: 34850937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
